MedPath

The effect of Melatonin on Fatigue in Multiple sclerosis patients

Phase 2
Conditions
Multiple Sclerosis.
Multiple sclerosis
Registration Number
IRCT2017030120258N35
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

multiple sclerosis with Mc.donald score; 18 to 50 years; ?Expanded Disability Status Scale (EDSS) 0 to 5.5; multiple sclerosis with IFN-B.
Exclusion criteria: pregnancy; ?patients with acute attack in 3 months ago; Lack of routine monitoring of ?patients. ?

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue. Timepoint: before treatment and 8 ?weeks after treatment. Method of measurement: standard fatigue questionnaire (FSS)?.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath